Pharmacosurveillance – Pharmacovigilance (2)


Accueil Programme synoptique Programme détaillé Posters Abstracts Anciens congrès Contact
Pharmacosurveillance – Pharmacovigilance (2) mercredi 16 juin 2021 Sessions parallèles de communications orales Sessions parallèles de communications orales • S31 • 09h00 > 10h00 • Pharmacosurveillance – Pharmacovigilance (2) • Salle 4 Sessions parallèles de communications orales Modérateurs : Valérie Gras-Champel, Marie-Blanche Valnet-Rabier • CO-007 • CO-007 - Drug-induced skin ulcers: a combined disproportionality analysis using data from Medline and Vigibase. > C. Charles Khouri • CO-008 • CO-008 - Improved detection statistical signals in pharmacovigilance by combining multiple variables from the reports > T. Thomas Berbain • CO-009 • CO-009 - Epidemiology of hospitalization due to adverse drug reactions in France: the IATROSTAT study > M-L. Marie-Laure Laroche • CO-010 • CO-010 - Amoxicillin-associated DRESS syndrome: Can drug-virus-immune system interaction explain its polymorphism? > B. Bérenger Largeau • CO-011 • CO-011 - Machine learning and semantic InformAtion for unstructured healthcare data: comparison of methods Through the Automatic analysIs of adverse drug reaction reports. MAI TAI study > L. Louis Létinier • CO-012 • CO-012 - Serious Adverse Care Reactions: description of the cases reported to the Rennes Pharmacovigilance Center > D. Dorine FOURNIER